The raised production limit follows the Food and Drug Administration's request in July, the DEA said in a notice on Tuesday.

When it comes to selecting a cost-effective, first-line tyrosine kinase inhibitor (TKI) for the treatment of chronic myeloid leukemia (CML), consider the treatment goal. For survival, generic ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Pharmaceutical leaders represent the biggest sector with 33 executives, followed by hospital facilities with 31 leaders, and ...

US FDA approved generic versions of Vyvanse from 11 drugmakers, including U.S.-based drugmakers Mallinckrodt and Viatris, UK-based Hikma Pharmaceuticals, and Indian drugmaker Sun Pharmaceutical ...

JS has received research support by the German Ministry of Education and Research BMBF, Basilea Pharmaceuticals, Noscendo; has received speaker honoraria by AbbVie, Gilead, Hikma and Pfizer ... of the ...

The global pharmaceutical CDMO market size is calculated at USD 184.9 billion in 2024 and is expected to achieve around USD 345.6 billion by 2033, representing a healthy CAGR of 7.2% from 2024 to 2033 ...

This medicine does exist, but it doesn’t come in a pill; instead, it comes as a “social prescription”—a referral to nonpharmaceutical, community-based resources and activities, like art ...

Iron Given Through the Vein Corrects Iron Deficiency Anaemia in Pregnant Women Faster and Better Than Iron Taken by Mouth Sep. 18, 2024 — Researchers found that a medicine called ferric ...

Hikma has completed its acquisition of Xellia Pharmaceuticals’ U.S. finished dosage form business and related assets following clearance under applicable U.S. antitrust laws. The acquisition ...